Everest Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Everest Management's ABBV Position: Q3 2026 in Review
Everest Management increased its AbbVie (ABBV) stake by 3.7% in Q3 2026, buying an estimated $11.8K and bringing the position to 1,298 shares worth $340K. The position accounts for 0.11% of the portfolio, ranked #71.
Everest Management first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Everest Management held 1,298 shares of AbbVie worth $340K as of Q3 2026.
- Everest Management bought 46 AbbVie shares in Q3 2026, an estimated $11.8K.
- AbbVie made up 0.11% of Everest Management's portfolio in Q3 2026, its #71 holding.
- Everest Management first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Everest Management's 13F filing for Q3 2026, filed 10 Nov 2026.